Inventor · disambiguated record
Christopher J. Bond
Also filed as: BOND CHRISTOPHER J · BOND CHRISTOPHER JOHN
18 granted patents·7 pending applications·188 citations·filing 2004–2022
94Inventor score
Files withONCOMED PHARM INC16CENTRE FOR DRUG RES AND DEVELOPMENT2GENENTECH INC2MEREO BIOPHARMA 5 INC2GURNEY AUSTIN L1
Top patents by PatentIndex Score
25 records- 0197US8858941B2VEGF/DLL4 binding agents and uses thereofONCOMED PHARM INC·Filed 2012·Granted Oct 14, 2014·31 cites·25 claims
- 0297US7785903B2Variable domain library and usesGENENTECH INC·Filed 2005·Granted Aug 31, 2010·75 cites·23 claims
- 0394US9023621B2Methods for identifying and isolating cells expressing a polypeptideONCOMED PHARM INC·Filed 2013·Granted May 5, 2015·13 cites·20 claims
- 0494US8551715B2Methods for identifying and isolating cells expressing a polypeptideGURNEY AUSTIN L·Filed 2011·Granted Oct 8, 2013·16 cites·19 claims
- 0593US9574009B2Polynucleotides encoding VEGF/DLL4 binding agentsONCOMED PHARM INC·Filed 2016·Granted Feb 21, 2017·8 cites·17 claims
- 0693US9376488B2VEGF binding antibodiesONCOMED PHARM INC·Filed 2014·Granted Jun 28, 2016·12 cites·16 claims
- 0792US9879084B2Modified immunoglobulin molecules that specifically bind human VEGF and DLL4ONCOMED PHARM INC·Filed 2017·Granted Jan 30, 2018·7 cites·20 claims
- 0891US8945878B2Methods for identifying and isolating cells expressing a polypeptideONCOMED PHARM INC·Filed 2013·Granted Feb 3, 2015·7 cites·19 claims
- 0988US9168300B2MET-binding agents and uses thereofONCOMED PHARM INC·Filed 2014·Granted Oct 27, 2015·6 cites·21 claims
- 1087US10730940B2VEGF/DLL4 binding agents and uses thereofONCOMED PHARM INC·Filed 2017·Granted Aug 4, 2020·1 cites·18 claims
- 1186US11512128B2VEGF/DLL4 binding agents and uses thereofMEREO BIOPHARMA 5 INC·Filed 2020·Granted Nov 29, 2022·1 cites·20 claims
- 1284US9181333B2RSPO3 binding agents and uses thereofONCOMED PHARM INC·Filed 2013·Granted Nov 10, 2015·5 cites·15 claims
- 1383US2023279101A1Vegf/dll4 binding agents and uses thereofMEREO BIOPHARMA 5 INC·Filed 2022·Application pending·0 cites
- 1480US9598497B2RSPO3 binding agents and uses thereofONCOMED PHARM INC·Filed 2015·Granted Mar 21, 2017·2 cites·21 claims
- 1576US11090383B2Anti-podocalyxin antibodies and methods of using the sameCENTRE FOR DRUG RES AND DEVELOPMENT·Filed 2016·Granted Aug 17, 2021·2 cites·18 claims
- 1674US9422546B2Methods for identifying and isolating cells expressing a polypeptideONCOMED PHARM INC·Filed 2015·Granted Aug 23, 2016·1 cites·19 claims
- 1768US2019062424A1Vegf/dll4 binding agents and uses thereofONCOMED PHARM INC·Filed 2018·Application pending·0 cites
- 1863US10960088B2Macrocycles, cobalt and iron complexes of same, and methods of making and using sameUNIV NEW YORK STATE RES FOUND·Filed 2014·Granted Mar 30, 2021·1 cites·13 claims
- 1963US9873726B2Methods for identifying and isolating cells expressing a polypeptideONCOMED PHARM INC·Filed 2016·Granted Jan 23, 2018·0 cites·17 claims
- 2061US2023060292A1Split chimeric antigen receptors and methods of useKITE PHARMA INC·Filed 2022·Application pending·0 cites
- 2156US12053524B2Anti-podocalyxin antibodies and methods of using the sameCENTRE FOR DRUG RES AND DEVELOPMENT·Filed 2021·Granted Aug 6, 2024·0 cites·17 claims
- 2253US2005079574A1Synthetic antibody phage librariesGENENTECH INC·Filed 2004·Application pending·0 cites
- 2353US2017267776A1RSPO3 Binding Agents and Uses ThereofONCOMED PHARM INC·Filed 2017·Application pending·0 cites
- 2448US2016319034A1Met-binding agents and uses thereofONCOMED PHARM INC·Filed 2014·Application pending·0 cites
- 2548US2016137744A1Met-binding agents and uses thereofONCOMED PHARM INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →